Rocket Pharmaceuticals, Inc.
RCKT· Nasdaq
Released Aug 9, 2023, after the close
10-Q filed Aug 9, 2023, 40 days after period end · 0001140361-23-038855
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$65.70M | -$54.40M | -$34.53M | -$25.04M |
| EPS Diluted | -$0.82 |
Rocket Pharmaceuticals, Inc. · CIK 1281895 · Engraved from SEC EDGAR
| -$0.83 |
| -$0.55 |
| -$0.45 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.